Role of TLRs and IL-6 in the outcome of chronic hepatitis C treatment in Tunisian population
Cytokine Aug 25, 2017
Sghaier I, et al. – The association between TLR3, TLR4 variants and nine IL–6 polymorphisms, and response to anti–viral treatment during HCV infection was examined. In the pathogenesis of viral infections, results revealed the contribution of TLR3 and TLR4. It was reported that the Th2 cytokine, IL–6, constituted a determinant of the outcome of therapy in HCV patients
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
